Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Block Listing Six Monthly Return

2 Jan 2019 07:00

RNS Number : 7694L
Ergomed plc
02 January 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 January 2019

 

Name of applicant:

Ergomed plc

Name of scheme:

Ergomed plc Long Term Incentive Plan

Period of return:

From:

2 July 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

1,800,000 (original admission)

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

55,000

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,745,000

Number and class of securities originally admitted and the date of admission

1,800,000 ordinary shares of 1p each - 2 July 2018

Total number of securities in issue at the end of the period

45,016,438 ordinary shares of 1p each

 

Name of contact:

Nick Blech - Deputy CFO

Telephone number of contact:

+44 (0)7768 547372

 

 Enquiries:

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)

Stuart Jackson (Chief Financial Officer)

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Broker)

 

Consilium Strategic Communications - for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

Matthew Neal / Olivia Manser

 

ergomed@consilium-comms.com

MC-Services - for Continental European enquiries

Tel: +49 211 5292 5222

Anne Hennecke

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFEWFWAFASEEE
Date   Source Headline
31st Oct 20233:30 pmRNSForm 8.3 - ERGO LN
31st Oct 20233:25 pmBUSForm 8.3 - Ergomed plc
31st Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
31st Oct 20238:35 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
30th Oct 20233:30 pmGNWForm 8.3 - Ergomed plc
30th Oct 20233:30 pmRNSForm 8.3 - ERGO LN
30th Oct 20233:25 pmBUSForm 8.3 - Ergomed plc
30th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
30th Oct 20231:53 pmGNWForm 8.3 - Ergomed Plc
30th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
27th Oct 20233:31 pmBUSForm 8.3 - Ergomed plc
27th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
27th Oct 20232:20 pmRNSForm 8.5 (EPT/RI) - Ergomed plc
27th Oct 20231:44 pmPRNForm 8.3 - Ergomed Plc
27th Oct 20231:01 pmGNWForm 8.3 - Ergomed Plc
27th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
27th Oct 20239:24 amRNSForm 8.5 (EPT/RI) - Ergomed plc
27th Oct 20237:00 amRNSSatisfaction of Conditions
26th Oct 20233:30 pmGNWForm 8.3 - Ergomed plc
26th Oct 20233:25 pmGNWForm 8.3 - [Ergomed Plc]
26th Oct 20233:25 pmBUSForm 8.3 - Ergomed plc
26th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
26th Oct 20233:08 pmRNSForm 8.3 - Ergomed PLC
26th Oct 20233:00 pmRNSForm 8.3 - Ergomed PLC
26th Oct 20232:18 pmRNSForm 8.3 - Ergomed Plc
26th Oct 20231:37 pmPRNForm 8.3 - Ergomed Plc
26th Oct 202312:20 pmRNSForm 8.3 - Ergomed PLC
26th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
26th Oct 202311:42 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
26th Oct 202310:52 amRNSForm 8.5 (EPT/RI) - Ergomed plc
26th Oct 20237:00 amBUSForm 8.3 - Ergomed PLC
25th Oct 20233:25 pmBUSForm 8.3 - Ergomed plc
25th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
25th Oct 20231:35 pmPRNForm 8.3 - Ergomed Plc
25th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
25th Oct 202311:04 amRNSForm 8.3 - Ergomed plc
24th Oct 20233:30 pmRNSForm 8.3 - ERGO LN
24th Oct 20233:30 pmGNWForm 8.3 - Ergomed plc
24th Oct 20233:25 pmBUSForm 8.3 - Ergomed plc
24th Oct 20233:20 pmRNSForm 8.3 - Ergomed plc
24th Oct 20233:09 pmRNSForm 8.3 - ERGOMED PLC
24th Oct 20233:00 pmRNSForm 8.3 - Ergomed PLC
24th Oct 20232:02 pmRNSForm 8.3 - Ergomed plc
24th Oct 202312:14 pmPRNForm 8.3 - Ergomed Plc
24th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
24th Oct 202311:17 amRNSForm 8.3 - Ergomed plc
24th Oct 202311:16 amRNSForm 8.3 - EMIS Group Plc
24th Oct 202311:07 amRNSIssue of Equity and Rule 2.9 Announcement
24th Oct 202310:50 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
24th Oct 20239:10 amBUSForm 8.3 - Ergomed Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.